KROS Quick Ratio Analysis

The quick ratio measures a company’s ability to cover immediate debts with its most liquid assets (cash, marketable securities, receivables).

At 21.93x, KROS holds $21.93 in liquid assets for every $1 of short-term liabilities, which is extremely high and indicates minimal short-term default risk. That ratio places KROS in the 100th percentile among Healthcare sector peers, far above the sector median of 1.08x. The ratio has been increasing over the last eight quarters, though the quarter-over-quarter change shows a slight dip of -0.8% (from 22.11x), and year-over-year data is not available. The combination of a very high level and a generally increasing trend signals very low liquidity risk, but also points to a potential inefficiency in deploying cash for growth; for a clinical-stage biotech, this cash hoard is typical and does not inherently signal opportunity or danger. This metric supports the overall NEUTRAL verdict because an extreme quick ratio is neither a strong positive nor negative for a pre-revenue healthcare company—it simply confirms the firm has ample cash to fund operations without indicating a compelling investment catalyst.

Frequently Asked Questions

Closest Sector Peers